Cholesterol, via sterol regulatory element-binding protein (SREBP) transcription factors, activates or represses genes involved in its hepatic biosynthetic pathway, and also modulates the expression of hepatocyte mitochondrial aquaporin-8 (mtAQP8), a channel that can function as peroxiporin by facilitating the transmembrane diffusion of H 2 O 2 . Here we tested the hypothesis that mtAQP8 is involved in the SREBP-mediated regulation of hepatocyte cholesterol biosynthesis. Using human hepatocyte-derived Huh-7 cells and primary rat hepatocytes, we found that mtAQP8 knockdown significantly downregulated de novo cholesterol synthesis as well as protein expressions of SREBP-2 and its target gene, a rate-limiting enzyme in cholesterol synthesis 3-Hydroxy-3-Methylglutaryl-CoA Reductase (HMGCR). In contrast, adenovirus-mediated human AQP8 mitochondrial expression significantly increased de novo cholesterol synthesis and protein expressions of SREBP-2 and HMGCR. In mtAQP8-overexpressed hepatocytes, mitochondrial H 2 O 2 release was found to be increased; and a mitochondria-targeted antioxidant prevented the upregulation of mitochondrial H 2 O 2 release and that of cholesterol synthesis. Our results suggest that peroxiporin mtAQP8 plays a role in the SREBP-controlled hepatocyte cholesterogenesis, a finding that might be relevant to cholesterol-related metabolic disorders.
Introduction
Aquaporin-8 (AQP8) is a water channel protein that can function as a peroxiporin by facilitating the transmembrane diffusion of H 2 O 2 [1] . AQP8 is expressed in the inner mitochondrial membrane of certain cells, including hepatocytes [2] . There is experimental evidence in human hepatocyte-derived cells [3] suggesting that mitochondrial AQP8 (mtAQP8) facilitates the diffusional release of H 2 O 2 .
In hepatocytes, cholesterol can activate or repress genes involved in its biosynthetic pathway via sterol regulatory element (SRE)-binding protein (SREBP) transcription factors [4] . SREBPs interact with SREs in promoter regions of genes encoding cholesterogenic enzymes, e.g., the key enzyme 3-Hydroxy-3-Methylglutaryl-CoA Reductase (HMGCR) [4] .
AQP8 has been identified as a putative cholesterol-responsive SREBP target gene by oligonucleotide microarray analysis in mouse liver [5, 6] . Moreover, we recently reported the cholesterol-induced transcriptional modulation of human hepatocyte mtAQP8 expression via SREBPs, i.e., mtAQP8 is upregulated in cholesterol-depleted cells and downregulated in cholesterol-loaded cells [7] . As H 2 O 2 has been reported to stimulate SREBP-mediated cholesterol synthesis in liver cells [8, 9] , we hypothesized that mtAQP8 plays a role in the SREBPmediated regulation of hepatocyte cholesterol biosynthesis.
Pierce ECL Western Blotting Substrate from Thermo Scientific, IL, USA; and Kodak XAR film from Eastman Kodak, NY, USA.
Culture of rat hepatocytes and human Huh-7 cells
Hepatocytes were isolated from normal livers of male Wistar rats by collagenase perfusion and mechanical disruption [10] . Cell viability (assessed by Trypan blue exclusion) was > 85%. Hepatocytes were plated onto collagen-coated glass plates at 1.9 × 10 4 cells/cm 2 . Primary rat hepatocytes and human Huh-7 (ATCC) cells were cultured in Dulbecco's Modified Eagle Medium (4.5 g/l), supplemented with 2 mM Lglutamine, 10 % heat-inactivated foetal calf serum and 100 I.U. penicillin/100 μg streptomycin at 37°C in a 5% CO 2 atmosphere. Media was changed every other day and Huh-7 cells were trypsinized after reaching confluency.
2.3. Synthesis of short interfering RNA (siRNA) and AQP8 knockdown
As we previously reported [3, 10] , the 21-nucleotide RNA duplexes were synthesized using the Silencer siRNA kit following the manufacturer's directions, with oligonucleotides synthesized by Invitrogen as templates. Two target sequences for each species were chosen. In studies using Huh-7 cells, siRNA1 and siRNA2 were specifically targeted to human AQP8 [3] , while in studies using rat hepatocytes, siRNA1 and siRNA2 were specifically targeted to rat AQP8 [10] . Corresponding control siRNAs (SCR) were designed by randomly scrambling the nucleotides of siRNA1 [3, 10] . After 18 h of culture, hepatic cells were transfected with their species-specific AQP8 siRNAs by using Lipofectamine 2000 transfection reagent following the manufacturer instructions. After 24 and 48 h of transfection, mtAQP8 protein expression was analyzed by immunoblotting.
Adenoviral transfection
AdhAQP8 is a replication-deficient bicistronic recombinant adenovirus vector serotype 5 that encodes for hAQP8 and Enhanced Green Fluorescent Protein (EGFP) ( Supplermentary Fig. S1 ). This adenovector was designed in our laboratory and produced in the laboratory of Molecular and Cellular Therapy, Instituto Leloir, Argentina. As control, we used a similar adenovector which encodes only for EGFP. Hepatocytes were incubated with AdhAQP8 at a multiplicity of infection 50 (added to the culture medium for 4 h at 37°C). The viral infection was stopped by replacing the culture medium, and the cells were cultured for additional 48 h. AQP8 protein expression was assessed by immunoblotting.
Immunoblotting
Western blot analyses were performed as described [7] . Whole cell lysates in RIPA buffer were used for HMGCR and SREBP-2 immunoblottings, while 6000×g postnuclear mitochondrial fractions in 0.3 M sucrose were used for mtAQP8 immunoblottings. Blots were incubated with goat (SC N-17) or mouse (SC 14-Z) affinity purified antibody which detects AQP8 of human and rat origin; or rabbit antibodies against HMGCR (H-300); or SREBP-2 (H-164) (Santa Cruz Biotechnology Inc., Santa Cruz, CA). For loading control, we used rabbit antibodies against prohibitin (Abcam, Cambridge, UK) or mouse antibodies against β-actin (Sigma, MO, USA). Densitometric analysis was performed using ImageJ Software.
Mitochondrial H 2 O 2 release in isolated mitochondria
H 2 O 2 release from isolated mitochondria was measured by using the Amplex™ Red-horseradish peroxidase assay kit as previously described [3] . For MitoTempo experiments, hepatocytes were incubated in the presence of 50 μM MitoTempo for 1 h before mitochondria isolation.
De novo cholesterol biosynthesis
Cholesterol de novo biosynthesis was measured by following the incorporation of radiolabeled acetate into cholesterol [11] . Forty-four hours after transfection, complete medium was replaced by culture medium containing 1 μCi of [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] C]acetic acid per well plus 250 μM sodium acetate for 4 h. For MitoTempo experiments, 30 h after transfection, hepatocytes were cultured in the presence of 50 μM MitoTempo for 1 h. At 48 h of transfections, cells were washed and scrapped with cold PBS. Total lipids were extracted, the organic phase was separated, and the solvent was evaporated under N 2 stream [11] . Afterwards, lipids were resuspended in 60 μL of chloroform and resolved by thin layer chromatography developed with 70:30:1 hexane:diethyl ether:-acetic acid. Resolved lipids were visualized with iodine vapor, and radioactive incorporation into cholesterol was quantified by scintillation counting (RackBeta 1214, Pharmacia Wallac Oy, Turku, Finland). Radioactivity was normalized to total protein of corresponding cell lysate.
Lactate dehydrogenase assay
Cell viability was evaluated by measuring the enzyme leakage with a commercial assay kit (Wiener Lab, Rosario, Argentina).
Statistical analysis
Data are expressed as means ± SEM. Significance was determined using Student's t-test or the 1-way ANOVA, Tukey test. P < 0.05 was considered as statistically significant.
Results

Downregulation of cholesterol synthesis in mtAQP8-knockdown hepatocytes
To decrease mtAQP8 expression, hepatocytes were transfected with species-specific siRNAs for AQP8. After 24 h of transfection, mtAQP8 expression and de novo cholesterol synthesis were unaffected in rat hepatocytes (Fig. 1A) or human hepatocyte-derived Huh-7 cells (Fig. 1B) . After 48 h, hepatocyte mtAQP8 protein expression decreased around 60-70% (Fig. 1A and B) . Cell viability assessed by lactate dehydrogenase leakage was unaffected by mtAQP8-knockdown in rat hepatocytes (siRNA1: 99 ± 10%; siRNA2: 97 ± 8%) or Huh-7 cells (siRNA1: 104 ± 3%; siRNA2: 99 ± 6%). Data are expressed as percentage of corresponding scramble and represent means ± SEM of three or four independent experiments. De novo cholesterol synthesis was significantly decreased by 35-50% in mtAQP8-knockdown cells (Fig. 1A and B) . In line with the reduced cholesterol synthesis, protein expressions of HMGCR and SREBP-2 (Fig. 1C) were found to be significantly down-regulated 40-50% in mtAQP8-knockdown cells. Taken together our data suggest that mtAQP8 knockdown downregulates hepatocyte cholesterogenesis via SREBP-2.
Upregulation of cholesterol synthesis in mtAQP8-overexpressed hepatocytes
Hepatocyte gene transfer of human AQP8 was performed by using the adenoviral vector AdhAQP8. Hepatocyte mtAQP8 protein expression clearly increased ( Fig. 2A) . Cell viability assessed by lactate dehydrogenase leakage was unaffected by AdhAQP8 (99 ± 2%; expressed as percentage of control adenovector and represent mean ± SEM of four independent experiments). De novo cholesterol synthesis significantly increased by about 70% in mtAQP8-overexpressed cells (Fig. 2A) . Accordingly, protein expressions of HMGCR and SREBP-2 (Fig. 2B) were markedly up-regulated in mtAQP8-overexpressed cells. Together, these data suggest that mtAQP8 overexpression induces the SREBP-mediated upregulation of hepatocyte cholesterogenesis.
MitoTempo prevented the mtAQP8-induced upregulation of cholesterol synthesis
Hepatocyte mtAQP8 overexpression significantly increased the mitochondrial release of H 2 O 2 which was prevented by mitochondriatargeted antioxidant MitoTempo (Fig. 3A) . MitoTempo also prevented the upregulation of cholesterol synthesis in mtAQP8-overexpressed cells (Fig. 3B ) without affecting mtAQP8 protein expression (Fig. 3C) . Cell viability assessed by lactate dehydrogenase leakage was unaffected by the treatments: 94 ± 7% (-AdhAQP8/+MitoTempo); 107 ± 6% (+AdhAQP8/-MitoTempo); 96 ± 7% (+AdhAQP8/+MitoTempo). Data are expressed as percentage of -AdhAQP8/-MitoTempo and represent means ± SEM of four independent experiments. These data suggest the involvement of mitochondria-derived H 2 O 2 in the upregulation of cholesterogenesis in mtAQP8-overexpressed hepatocytes. Representative immunoblottings for mtAQP8 with corresponding densitometric analysis related to prohibitin in mitochondrial fractions of human hepatocytederived Huh-7 cells transfected for 24 or 48 h with siRNAs specific for human AQP8 or control scramble (SCR). Right: De novo cholesterol synthesis in mtAQP8-knockdown human hepatocytes. De novo cholesterol synthesis in control (SCR) rat hepatocytes and Huh-7 cells were 1097 ± 91 and 5167 ± 301 DPM/mg of total protein, respectively. These values did not differ from untreated cells. (C) Representative immunoblotings for HMGCR and SREBP-2 from mtAQP8-knockdown human hepatocytes, and corresponding densitometric analysis related to α-tubulin or β-actin, respectively. Data are percentages of corresponding SCR and represent means ± SEM of 4 independent experiments. *P < 0.05 from SCR.
Discussion
The major finding in this study relates to the role of peroxiporin mtAQP8 in hepatocyte cholesterol synthesis. We provide experimental evidence that (i) mtAQP8 knockdown downregulated cholesterol synthesis and protein expressions of SREBP-2 and HMGCR; (ii) mtAQP8 overexpression upregulated cholesterol synthesis and protein expressions of SREBP-2 and HMGCR; (iii) mtAQP8 overexpression increased AQP8-knockdown studies in human hepatocyte-derived cells [3] and rat hepatocytes [12, Fig. 1] , together with present study in AQP8-overexpressed rat hepatocytes (Fig. 3) indicate that mtAQP8 facilitates the membrane-conditioned, diffusional efflux of H 2 O 2 across hepatocyte mitochondrial membranes. Mitochondrial-derived H 2 O 2 signaling is implicated in diverse biochemical pathways [13, 14] and, as suggested by our results, it may be also involved in hepatic cholesterol biosynthesis. In line with this, hepatic cells exposed to low levels of H 2 O 2 show SREBP activation and increased cholesterol synthesis [8, 9] . Interestingly, insulin is able to stimulate liver mitochondrial H 2 O 2 generation and release [15] and thus, a mitochondrial redox signaling might be involved in insulin-induced hepatic cholesterogenesis.
In HeLa cells, plasma membrane AQP8 has been demonstrated to facilitate the diffusional influx of NOX-generated H 2 O 2 which participates in tyrosine kinase signaling pathways [16] . In hepatocytes, besides its mitochondrial localization, AQP8 is expressed on the bile canalicular plasma membrane and therefore it cannot be involved in the uptake of H 2 O 2 generated by NOX proteins located on sinusoidal plasma membranes. It is worth mentioning that rat hepatocytes in primary culture progressively lose protein expressions of plasma membrane transporters including AQP8. Thus, contrarily to mtAQP8 protein expression that remains stable over time, the expression of plasma membrane AQP8 declines in hepatocytes after 24 h of culture being almost undetectable after 72 h (i.e., the time of our experiments) [10] . Thus primary rat hepatocytes are particularly useful in mtAQP8 knockdown studies. Nevertheless, AdhAQP8-transduced hepatocytes expressed a fraction of hAQP8 on plasma membranes (data not shown). Therefore, to get some insight into an eventual contribution of NOX proteins in hAQP8-induced cholesterogenesis, we made use of the NOX inhibitor apocynin [17] . Interestingly, either basal or hAQP8-induced cholesterol de novo synthesis was not significantly altered by apocynin ( Supplementary Fig. S2 ). Although further experiments should be done, this finding suggests that hepatocyte NOX proteins do not play a critical role in hAQP8-induced cholesterogenesis.
Mitochondrial AQP8 can also function as ammoniaporin [18] , that is, facilitating the ammonia diffusion into mitochondria for its metabolization to urea [10, 19] . Ureagenesis and hepatic lipid metabolism have been suggested to play interactive roles [20] , nevertheless, to the best of our knowledge, there is no study that relates ammonia-derived ureagenesis and cholesterol synthesis. In order to gain some insight into the impact of mtAQP8-mediated ammonia transport and ureagenesis on cholesterol biosynthesis, hepatocytes were incubated in the presence of ammonia [10] . Under this condition, basal or hAQP8-induced cholesterol de novo synthesis was not significantly altered ( Supplementary Fig.  S3 ). These data, together with the fact that in mtAQP8-overexpressed cells, mitoTempo inhibited mitochondrial H 2 O 2 release and cholesterol synthesis (Fig. 3) but not ammonia-derived ureagenesis (data not shown) suggests that mtAQP8 working as peroxiporin, but not as ammoniaporin, plays a role in the modulation of hepatocyte cholesterol synthesis.
It has been reported that mitochondria-derived H 2 O 2 can activate hepatic MAPK (mitogen-activated protein kinases) family members by inhibiting MAPK-inactivating phosphatases [21] [22] [23] [24] [25] . On the other hand, SREBPs are targets of MAPKs, and MAPK-induced phosphorylation leads to SREBP activation [26, 27] . Thus, the involvement of an mtAQP8-H 2 O 2 -MAPK signaling pathway in SREBP-controlled cholesterogenesis is plausible.
Based on our previous [7] and present observations, we propose that when hepatocyte cholesterol is low; SREBP2-activation leads to upregulation of key cholesterogenic enzymes (e.g., HMGCR) as well as peroxiporin mtAQP8. The facilitated release of mitochondrial H 2 O 2 promotes a positive feedback signaling for upregulation of SREBP-2 and consequently cholesterol synthesis. When hepatocyte cholesterol content rises, the transcription of SREBP-responsive genes (i.e., cholesterogenic enzymes and mtAQP8) ceases (Fig. 4) . 
